Latest Regulatory Approvals News

Brookfield has agreed to acquire ESR's remaining 19.9% stake in Cromwell Property Group, pending regulatory approval, signaling a major consolidation in the Australian real estate sector.

Argosy Minerals Limited has launched a $2 million placement accompanied by an offer of up to 40 million options, aiming to bolster development and feasibility efforts at its Rincon Lithium Project in the USA.

Enova Mining has revealed significant near-surface titanium oxide and rare earth element mineralisation from initial auger drilling at its CODA Central Project in Brazil, highlighting the project's multi-commodity potential.

Solara Minerals has agreed to acquire a portfolio of seven exploration licences in Western Australia's Murchison region, positioning itself near major gold and copper mines. The deal includes immediate exploration plans and potential milestone-based share payments.

Aeris Resources reported a robust June 2025 quarter with increased copper and gold production, improved cost efficiencies, and successful refinancing, while advancing exploration at key projects.

Manhattan Corporation has secured regulatory approvals to begin field activities at its Hook Lake Project in Nunavut, Canada, targeting a historic high-grade gold deposit and polymetallic prospects. Initial work aims to validate past data and prepare for a maiden drilling campaign.

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

Cazaly Resources confirms robust gold mineralisation at Duke of York and discovers a promising new target, Duchess, at its Goongarrie Gold Project. Early drilling results and reprocessed geophysics set the stage for expanded exploration.

Tivan and Sumitomo Corporation have formalised their joint venture for the Speewah Fluorite Project, securing a strategic investment from Japan’s JOGMEC. This partnership marks a significant step towards advancing the project’s feasibility and strengthening Australia-Japan critical minerals ties.

PainChek has completed its final FDA submission for the PainChek Adult App, targeting the US long-term care market with a potential $100 million annual opportunity. A regulatory decision is expected within 75 days, setting the stage for rapid commercialisation.

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.

DeSoto Resources reports standout shallow gold intercepts up to 71.2 g/t Au from recent power auger drilling at its Tole Project in Guinea, highlighting promising exploration potential across its extensive Siguiri Basin holdings.